Intracoronary abciximab and local anti-inflammatory effects

International Journal of Cardiology

Volumn 168, Issue 3, 2013, Pages 2872-

  Dominguez Rodriguez, Alberto ^a,b,c   Avanzas, Pablo ^d   Abreu Gonzalez, Pedro ^c,e  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b Facultad de Ciencias de la Salud   (Spain)

^c Instituto Universitario de Tecnología Biomédicas   (Spain)

^d HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^e UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

Abciximab; Acute coronary syndrome; Antiinflammatory; Intracoronary

Indexed keywords

ANTITHROMBOCYTIC AGENT; IMMUNOGLOBULIN F(AB) FRAGMENT; MONOCLONAL ANTIBODY;

ACUTE CORONARY SYNDROME; HUMAN; MORTALITY;

ACUTE CORONARY SYNDROME; ANTIBODIES, MONOCLONAL; HUMANS; IMMUNOGLOBULIN FAB FRAGMENTS; PLATELET AGGREGATION INHIBITORS;

EID: 84885650713     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2013.03.142     Document Type: Article

References (6)

1. S. De Rosa, G. Caiazzo, D. Torella, and C. Indolfi Intracoronary abciximab reduces death and major adverse cardiovascular events in acute coronary syndromes: a meta-analysis of clinical trials Int J Cardiol 2012 10.1016/j.ijcard.2012.12.003
2. L. Badimón, G. Vilahur, and T. Padró Lipoproteins, platelets and atherothrombosis Rev Esp Cardiol 62 2009 1161 1178
3. J.L. Martín-Ventura, L.M. Blanco-Colio, and J. Tuñón Biomarkers in cardiovascular medicine Rev Esp Cardiol 62 2009 677 688
4. I. Eitel, S. Desch, K. Schindler, G. Fuernau, G. Schuler, and H. Thiele Aborted myocardial infarction in intracoronary compared with standard intravenous abciximab administration in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction Int J Cardiol 153 2011 21 25
5. M.I. Furman, L.A. Krueger, and M.D. Linden GPIIb-IIIa antagonists reduce thromboinflammatory processes in patients with acute coronary syndromes undergoing percutaneous coronary intervention J Thromb Haemost 3 2005 312 320
6. A. Dominguez-Rodriguez, P. Abreu-Gonzalez, and P. Avanzas Intracoronary versus intravenous abciximab administration in patients with ST-elevation myocardial infarction undergoing thrombus aspiration during primary percutaneous coronary intervention - effects on soluble CD40 ligand concentrations Atherosclerosis 206 2009 523 527